Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

scientific article published on 22 October 2015

Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/JHG.2015.120
P698PubMed publication ID26490187

P50authorKeiichi KoshizukaQ86533788
Naohiko SekiQ90079422
Hideki EnokidaQ90787285
P2093author name stringYoshitaka Okamoto
Masayuki Nakagawa
Rika Nishikawa
Ryosuke Matsushita
Yusuke Goto
Toyoyuki Hanazawa
Akira Kurozumi
Naoko Kikkawa
Ichiro Fukumoto
Mayuko Kato
P2860cites workThe role of miR-26 in tumors and normal tissues (Review)Q24629056
Circulating tumour cells in metastatic head and neck cancersQ26858916
MicroRNAs: genomics, biogenesis, mechanism, and functionQ27861070
Extracellular matrix as target for antitumor therapyQ28082018
Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinomaQ28118099
miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancerQ28236303
Tumor-suppressive microRNA-218 inhibits cancer cell migration and invasion via targeting of LASP1 in prostate cancerQ30009425
Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.Q33559304
The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1Q33673803
Identification of tumour suppressive microRNA-451a in hypopharyngeal squamous cell carcinoma based on microRNA expression signatureQ33918123
miR-489 is a tumour-suppressive miRNA target PTPN11 in hypopharyngeal squamous cell carcinoma (HSCC).Q34130721
Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor.Q34163575
Distribution volumes of macromolecules in human ovarian and endometrial cancers--effects of extracellular matrix structureQ48254850
Tumour suppressive microRNA-874 regulates novel cancer networks in maxillary sinus squamous cell carcinomaQ34208496
LOXL2 in epithelial cell plasticity and tumor progressionQ34303455
Current management strategy of hypopharyngeal carcinomaQ34308054
Lysyl hydroxylase 3 glucosylates galactosylhydroxylysine residues in type I collagen in osteoblast cultureQ34684864
Hypoxia and the extracellular matrix: drivers of tumour metastasisQ34820282
Lysyl oxidase-like 2 represses Notch1 expression in the skin to promote squamous cell carcinoma progression.Q35527142
MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathwaysQ35678702
MRC-5 fibroblast-conditioned medium influences multiple pathways regulating invasion, migration, proliferation, and apoptosis in hepatocellular carcinomaQ35869684
Microenvironmental control of the breast cancer cell cycleQ35922924
Akt1 mediates prostate cancer cell microinvasion and chemotaxis to metastatic stimuli via integrin β₃ affinity modulation.Q36166788
Metastatic bladder cancer cells distinctively sense and respond to physical cues of collagen fibril-mimetic nanotopographyQ36191451
HSP47 regulates ECM accumulation in renal proximal tubular cells induced by TGF-β1 through ERK1/2 and JNK MAPK pathwaysQ36309370
Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical studyQ36468724
The role of microRNAs in cancer: no small matter.Q36832677
Integrins and metastasisQ37014793
MicroRNAs--micro in size but macro in functionQ37255242
MicroRNAs in cancer: small molecules with a huge impactQ37474280
Activation of the NOTCH pathway in head and neck cancerQ37621332
Post-transcriptional regulatory network of epithelial-to-mesenchymal and mesenchymal-to-epithelial transitionsQ37681322
Current trends in initial management of hypopharyngeal cancer: the declining use of open surgeryQ37974164
The rationale for targeting the LOX family in cancerQ38027412
microRNAs are important players in head and neck carcinoma: a reviewQ38129177
MicroRNA Deregulations in Head and Neck Squamous Cell CarcinomasQ38178272
Diverse roles of miR-29 in cancer (review).Q38191459
Human lysyl oxidase-like 2.Q38242121
MiR-218 mediates tumorigenesis and metastasis: Perspectives and implicationsQ38413091
Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinomaQ38861461
Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma.Q38973071
Protein O-fucosyltransferase 1: a potential diagnostic marker and therapeutic target for human oral cancerQ39092173
LOXL2 expression is associated with invasiveness and negatively influences survival in breast cancer patients.Q39112374
Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinomaQ39243346
Functional analysis of LOXL2 in pancreatic carcinomaQ39763088
Oral cancer cells with different potential of lymphatic metastasis displayed distinct biologic behaviors and gene expression profilesQ39813090
New and paradoxical roles of matrix metalloproteinases in the tumor microenvironment.Q42239363
Lysyl oxidase and enhancement of cell proliferation and angiogenesis in oral squamous cell carcinoma.Q42720975
P433issue2
P921main subjectmicroRNAQ310899
P304page(s)109-118
P577publication date2015-10-22
P1433published inJournal of Human GeneticsQ6295302
P1476titleTumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma
P478volume61

Reverse relations

cites work (P2860)
Q91650451Comparison of tumour and serum specific microRNA changes dissecting their role in pancreatic ductal adenocarcinoma: a meta-analysis
Q33728303Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs
Q38771636Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.
Q49218679Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma
Q47912856Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma.
Q38723997Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and Cancer
Q47568135MiR-29a: a potential therapeutic target and promising biomarker in tumors
Q49790324MicroRNA-26a and Tumor
Q98782032MicroRNA-29a functions as a tumor suppressor through targeting STAT3 in laryngeal squamous cell carcinoma
Q92444215MicroRNAs and Metastasis
Q38726489Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer
Q38754000Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis
Q91643917Regulation of Oncogenic Targets by miR-99a-3p (Passenger Strand of miR-99a-Duplex) in Head and Neck Squamous Cell Carcinoma
Q39384713Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.
Q38765720Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.
Q48301918Role of non-coding RNAs in head and neck squamous cell carcinoma: A narrative review.
Q33740486Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
Q64064521The Role of MicroRNAs in Recurrence and Metastasis of Head and Neck Squamous Cell Carcinoma
Q38936321The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.
Q101410380microRNAs deregulation in head and neck squamous cell carcinoma

Search more.